| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/03/2005 | WO2004075835A3 Methods for the treatment of renal cell carcinoma |
| 03/03/2005 | WO2004072269A9 Bex4 nucleic acids, polypeptides, and method of using |
| 03/03/2005 | WO2004072265A3 Methods for monitoring drug activities in vivo |
| 03/03/2005 | WO2004071411A3 Methods and compositions in treating pain and painful disorders using 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 |
| 03/03/2005 | WO2004071395A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r) |
| 03/03/2005 | WO2004070383A3 Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis |
| 03/03/2005 | WO2004063962A3 Linkage analysis using direct and indirect counting |
| 03/03/2005 | WO2004062627A3 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |
| 03/03/2005 | WO2004059278A3 Methods of screening for anti-inflammatory drugs and use thereof |
| 03/03/2005 | WO2004059001A3 Method for determining markers of human facial skin |
| 03/03/2005 | WO2004058185A3 Antiangiogenesis by inhibiting protein kinase ck2 activity |
| 03/03/2005 | WO2004053459A3 Compounds and mehtods of use thereof for assaying lysophospholipase d activity |
| 03/03/2005 | WO2004048937A3 Electro-optical nucleic acid-based sensor array and method for detecting analytes |
| 03/03/2005 | WO2004039894A3 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 03/03/2005 | WO2004034060A3 Isolated post-translationally modified proteins for monitoring and diagnosing muscle damage |
| 03/03/2005 | WO2004025256A3 Viral deconstruction through capsid assembly in vitro |
| 03/03/2005 | WO2004004668A3 Immune modulatory activity of human ribonucleases |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | WO2003100006A3 Method of improved prostate cancer detection |
| 03/03/2005 | WO2003091418A3 Novel essential fungal polynucleotides, polypeptides, and methods of use |
| 03/03/2005 | WO2003082096A8 System and method for managing a patient treatment program |
| 03/03/2005 | WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 03/03/2005 | WO2003014726A8 A lateral flow plasma separation device |
| 03/03/2005 | WO2003012439A3 Method for calculating a biological characteristic property of a molecule by correlation analysis |
| 03/03/2005 | WO2003009943A8 System for separating magnetically attractable particles |
| 03/03/2005 | WO2002074911A3 Identification of gene expression alterations underlying the aging process in mammals |
| 03/03/2005 | WO2002062203A9 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/03/2005 | US20050050594 Enzyme inhibitors; competitive binding |
| 03/03/2005 | US20050050129 Method of estimating a penetrance and evaluating a relationship between diplotype configuration and phenotype using genotype data and phenotype data |
| 03/03/2005 | US20050049797 Method and system for displacement-vector-based detection of zone misalignment in microarray data |
| 03/03/2005 | US20050049796 Methods for encoding non-biological information on microarrays |
| 03/03/2005 | US20050049795 Biological sequence information reading method and storing method |
| 03/03/2005 | US20050049794 Processes for producing optimized pharmacophores |
| 03/03/2005 | US20050049793 Prenatal diagnosis method on isolated foetal cell of maternal blood |
| 03/03/2005 | US20050049406 Isotopically coded affinity markers 3 |
| 03/03/2005 | US20050049401 Immunoglobulin specific to fertility-associated antigen for use in monitoring reproductive status and diagnosing fertility disorders; animal husbandry and in vitro fertiization |
| 03/03/2005 | US20050049398 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 03/03/2005 | US20050049396 Nondestructive imaging protein for visualizing/monitoring spatial and temporal gene expression in living cells, animal and plant bodies |
| 03/03/2005 | US20050049395 Models of prion disease |
| 03/03/2005 | US20050049257 e.g., 5-[6-(dimethylamino)-4-methylpyridin-3-yl]-N-[(1R,2S)-2ethoxy-2,3-dihydro-1H-inden-1-yl]-3,6-diethylpyrazin-2-amine; used in treating anxiety disorders, depression and stress related disorders |
| 03/03/2005 | US20050049230 Compounds that act to modulate insect growth and methods and systems for identifying such compounds |
| 03/03/2005 | US20050049214 Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders |
| 03/03/2005 | US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides |
| 03/03/2005 | US20050049201 Detection and removal of lead using lead-binding proteins |
| 03/03/2005 | US20050049198 Contacting a cardiac ryanodine receptor (RyR2) with a fragment of a dihydropyridine receptor (DHPR) polypeptide; ischemic heart disease, congestive heart failure, cardiac hypertrophy (calcium overload), dysrhythmia, or heart attack, cardiomyopathy |
| 03/03/2005 | US20050049195 Methods and compositions for nerve regeneration |
| 03/03/2005 | US20050049184 Blood treatment using antibodies which bind to non-glycosylated leptin transport factor and/or to enzymes responsible for reducing blood concentrations of the glycosylated factor |
| 03/03/2005 | US20050048673 Method for detecting analyte(s) using magnetic colloidal particles |
| 03/03/2005 | US20050048672 Using variation in resonant frequency of immobilized biopolymers as diagnostic tool in detection of preferential particles in mixture |
| 03/03/2005 | US20050048671 Gap junction-containing devices for detecting biochemical activity |
| 03/03/2005 | US20050048666 Method and device for monitoring medication usage |
| 03/03/2005 | US20050048664 Hydrogen peroxide solution for use in detection of animal blood |
| 03/03/2005 | US20050048663 Composition and method for detecting an adulterant in an aqueous sample |
| 03/03/2005 | US20050048660 Biomarker of maternal alcohol use during pregnancy |
| 03/03/2005 | US20050048657 Method of using a hematology control product |
| 03/03/2005 | US20050048656 Quality control method |
| 03/03/2005 | US20050048655 Kit for detecting endotoxin |
| 03/03/2005 | US20050048651 Method and apparatus for spatially confined electroporation |
| 03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
| 03/03/2005 | US20050048599 Multicompartment electrophoretic apparatus for quantifying microorganisms in solution; drug screening and microbiocides |
| 03/03/2005 | US20050048596 Assay for detecting changes in mitochondrial membrane permeability and method of using same |
| 03/03/2005 | US20050048595 Bioassay unit and substrate for bioassay |
| 03/03/2005 | US20050048594 Fluorine NMR spectroscopy for biochemical screening |
| 03/03/2005 | US20050048591 Activating mixture of dioxetane derivative with cationic surfactant and fluorescent material by contacting with base, acid, salt, fluorine compound, enzyme or catalyst as activator to convert phenyl substituent into carbonyl compound via an unstable oxide intermediate |
| 03/03/2005 | US20050048590 Streptococcal enolase for use in generating immunoglobulins for use in prevention and treatment of microorganismal infection; immunotherapy |
| 03/03/2005 | US20050048588 Mimetic amino acid sequences for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy; genetic vaccines |
| 03/03/2005 | US20050048587 Identifying immunomodulatory agents via contacting lymphocytes mixture with antisense RNA and monitoring variation in marker gene expression; gene expression inhibition |
| 03/03/2005 | US20050048586 Using taste transduction G-protein coupled receptor polypeptides as diagnostic tools which identify modulators which enhance flavors and taste |
| 03/03/2005 | US20050048585 Identifying modulators of nuclear factor of activated t-cells (NF-AT) actvity for use in treatment of cell proliferative and autoimmune diseases; immunosuppressants |
| 03/03/2005 | US20050048584 Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof |
| 03/03/2005 | US20050048583 Immobilized carbohydrate biosensor |
| 03/03/2005 | US20050048582 Method for the detection of prion diseases |
| 03/03/2005 | US20050048581 Imaging morphologies and subcellular architectures of ultrasmall structures within cells |
| 03/03/2005 | US20050048580 Microarray for use in producing a protein-interaction map; proteomics, genomics and high throughput analysis |
| 03/03/2005 | US20050048579 Using three dimensional structure of cellular adhesion molecule to drug design non-peptide modulator of cellular adhesion molecule activity; designing drugs for treatment of cell proliferative and autoimmune diseases |
| 03/03/2005 | US20050048578 Methods of screening for monoclonal antibodies with desirable activity |
| 03/03/2005 | US20050048576 Diagnosing/prognosing nut allergies; immunodiagnostics |
| 03/03/2005 | US20050048575 Multi-well plate providing a high-density storage and assay platform |
| 03/03/2005 | US20050048574 Biomarkers for diagnosing rheumatoid arthritis |
| 03/03/2005 | US20050048573 PDE5A crystal structure and uses |
| 03/03/2005 | US20050048570 Solid support comprising microstructures containing biofunctionalized nanoparticles for use in detecting infection; disease diagnosis; bioinformatics |
| 03/03/2005 | US20050048569 Classifying g-protein coupled receptor via structural homologies; identifying cell signaling modulators |
| 03/03/2005 | US20050048568 High sensitivity protein workstation and techniques |
| 03/03/2005 | US20050048567 For mass spectrometry; ceramidases; drug screening |
| 03/03/2005 | US20050048566 Using high throughput assay to monitor differential protein expression in cells; bioinformatics and proteomics |
| 03/03/2005 | US20050048565 Method of diagnosing or monitoring saccharometabolic error |
| 03/03/2005 | US20050048564 Protein expression profile database |
| 03/03/2005 | US20050048563 Membrane molecule indicator compositions and methods |
| 03/03/2005 | US20050048561 Using polydimethylsiloxane channel comprising immobilized biopolymers for rapid detection and quantification of multiple targets; cancer diagnostics |
| 03/03/2005 | US20050048559 Compositions and methods relating to breast specific genes and proteins |
| 03/03/2005 | US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides |
| 03/03/2005 | US20050048553 Multiplexed analysis by chromatographic separation of molecular tags |
| 03/03/2005 | US20050048551 Comprises carrier body bound with analyte having fluorescence-labeled part that can emit fluorescence by light received when distance between is enlarged, and detector for measuring electric potentials |
| 03/03/2005 | US20050048550 Ephrin-A2 lymphocyte receptor modulator for use in treatment and prevention of renal cell carcinoma; mimetics and antitumor agents |
| 03/03/2005 | US20050048547 Identifying biomarkers associated ovarian cancer; diagnostic/prognostic tool for detecting cell proliferative disorders |
| 03/03/2005 | US20050048545 Immunodiagnostic assay comprising antibody fusion and its cognate antigen for use in detecting antigen-antibody binding events |
| 03/03/2005 | US20050048542 Expression profile algorithm and test for cancer prognosis |
| 03/03/2005 | US20050048540 Multicompartment apparatus comprising gene binding carrier and injection ports for use in isolation, characterization and extraction of preferential gene sequences |
| 03/03/2005 | US20050048539 Using fluorescent lifetime/half-life as measurement tool in determining distance between presenilin 1 and amyloid precursor proteins; gene expression and genetic characterization |
| 03/03/2005 | US20050048535 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |